The increased expression of a variety of TGF-β-targeting miRNAs in naïve CD4 + T cells of MS patients impairs TGF-β signaling and inhibits the development of Tregs, thereby increasing the susceptibility to MS. Here, TGFB1 is linked to myeloid sarcoma.